Ampicillin-Sulbactam Lock Therapy: Preparation and Administration Protocol
For ampicillin-sulbactam lock therapy in hemodialysis catheters, prepare a solution containing ampicillin 10 mg/mL combined with heparin at either 10 IU/mL or 5,000 IU/mL, instill 2–5 mL into each catheter lumen after every dialysis session, and always combine with systemic antibiotics for 10–14 days. 1, 2
Indications and Patient Selection
Antibiotic lock therapy is appropriate only when:
- The patient has confirmed catheter-related bloodstream infection (CRBSI) with ampicillin-susceptible Enterococcus species 1
- Clinical improvement occurs within 2–3 days of starting systemic antibiotics (resolution of fever, chills, hemodynamic instability) 2
- No exit-site infection, tunnel infection, or metastatic complications (endocarditis, osteomyelitis, suppurative thrombophlebitis) are present 2
- Catheter salvage is the goal and no alternative vascular access site exists 2
Critical contraindications requiring immediate catheter removal:
- Staphylococcus aureus, Pseudomonas species, or Candida species infections 2, 3
- Persistent bacteremia beyond 72 hours despite appropriate therapy 2, 3
- Any exit-site, tunnel, or metastatic infection 2
Antibiotic Solution Preparation
Step-by-step preparation of ampicillin-sulbactam lock solution:
Antibiotic Concentration
- Final concentration: Ampicillin 10 mg/mL (which corresponds to ampicillin-sulbactam 15 mg/mL in the 2:1 fixed combination) 1
- This concentration will not precipitate and remains stable 1
Heparin Dose Options
Two validated heparin concentrations are available: 1
- Option 1: 10 IU/mL heparin (lower concentration)
- Option 2: 5,000 IU/mL heparin (higher concentration)
Both concentrations are physically compatible with ampicillin 10 mg/mL and maintain stability for at least 14 days 4. The choice between these concentrations depends on institutional protocols, though the lower concentration (10 IU/mL) minimizes systemic anticoagulation risk while the higher concentration (5,000 IU/mL) may provide additional thrombosis prevention 5.
Preparation Method
Using ampicillin-sulbactam vials (typically 1.5 g or 3 g):
Reconstitute the ampicillin-sulbactam powder with Sterile Water for Injection to achieve 375 mg/mL (250 mg ampicillin/125 mg sulbactam per mL) 6
- For 1.5 g vial: add 3.2 mL diluent, withdraw 4.0 mL
- For 3 g vial: add 6.4 mL diluent, withdraw 8.0 mL
Dilute to final lock concentration:
Add heparin:
- For 10 IU/mL final concentration: Add 0.01 mL of heparin 1,000 IU/mL per mL of antibiotic solution
- For 5,000 IU/mL final concentration: Add 1 mL of heparin 5,000 IU/mL per mL of antibiotic solution 1
Mix thoroughly by gentle agitation for approximately 10 seconds 1
Stability Considerations
- Solutions remain physically compatible and biologically active for at least 14 days when stored properly 4, 7
- Heparin activity remains stable (variation <16.4% from baseline) throughout this period 4
- Use freshly prepared solutions when possible and discard any unused portions after the recommended storage period 6, 7
Administration Procedure
Lock therapy protocol at each dialysis session:
Flush each catheter lumen with 5–10 mL of normal saline using turbulent (push-pause) technique to clear residual blood 5
Determine lock volume: Use 2–5 mL per lumen, sufficient to fill the internal catheter volume without systemic administration 2, 5
Instill the ampicillin-sulbactam/heparin lock solution into each lumen using aseptic technique 2, 5
Allow the solution to dwell until the next dialysis session (typically 48–72 hours for thrice-weekly dialysis) 2, 5
Renew the lock solution after every dialysis session throughout the treatment course 1, 2, 5
Mandatory Concurrent Systemic Therapy
Antibiotic lock must never be used as monotherapy: 2, 3
- Always combine with systemic antibiotics administered intravenously 2, 3
- Duration: Both lock therapy and systemic antibiotics should be given for 10–14 days 2, 3
- Empiric systemic regimen for hemodialysis patients: Vancomycin 20 mg/kg loading dose during the last hour of dialysis, then 500 mg during the last 30 minutes of subsequent sessions, plus gram-negative coverage (ceftazidime 1 g or cefazolin 20 mg/kg after each session) 1, 3
- Targeted therapy: Once susceptibilities return showing ampicillin-susceptible Enterococcus, systemic ampicillin-sulbactam can be administered (dosing adjusted for dialysis schedule) 3
Rationale for High Antibiotic Concentrations
The 10 mg/mL concentration is necessary because:
- Sessile bacteria within catheter biofilm require antibiotic concentrations 100–1,000 times higher than the minimum inhibitory concentration (MIC) for eradication 2, 5
- Standard systemic dosing cannot achieve these supratherapeutic local concentrations 2
- Lock therapy delivers these high concentrations directly to the site of infection within the catheter lumen 2, 8, 9
Expected Outcomes and Monitoring
Success rates for ampicillin-sulbactam lock therapy:
- Ampicillin is the preferred agent for ampicillin-sensitive Enterococcus species 1
- Gram-negative organisms: 87–100% cure rate 2, 5
- Coagulase-negative staphylococci: 75–84% cure rate 2, 5
- Enterococcus species typically respond well when ampicillin-susceptible 1, 2
Mandatory follow-up:
- Obtain surveillance blood cultures 1 week after completing therapy if the catheter was retained 2, 3
- If follow-up cultures are positive, remove the catheter immediately and place a new catheter only after negative cultures are documented 2
Critical Pitfalls to Avoid
Common errors that compromise outcomes:
Using lock therapy alone without systemic antibiotics – this approach fails because lock therapy only treats intraluminal infection, not bloodstream or extraluminal infection 2, 3
Attempting lock therapy for S. aureus infections – success rates are only 40–55%, mandating catheter removal instead 2, 5
Failing to renew the lock after each dialysis session – the lock solution is removed when the catheter is accessed for dialysis and must be reinstilled 2, 5
Using excessive heparin doses – confusing concentration (IU/mL) with total dose can lead to administering 12,500 units per lumen instead of the appropriate amount 5
Inadequate saline flushing before lock instillation – residual blood in the lumen can inactivate antibiotics and promote clot formation 5
Continuing therapy beyond 72 hours without clinical improvement – persistent symptoms mandate catheter removal 2, 3
Duration and Extended Therapy Scenarios
Standard duration: 10–14 days of combined lock and systemic therapy 2, 3
Extended therapy required for: